During the past decade, Virginia Research Center conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 7 clinical trials were completed, i.e. on average, 87.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Virginia Research Center" #1 sponsor was "Pfizer" with 6 trials, followed by "BioNTech SE" with 4 trials sponsored, "Acerus Pharmaceuticals Corporation" with 1 trials sponsored, "Purdue Pharma LP" with 1 trials sponsored and "Sucampo Pharma Americas, LLC" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Virginia Research Center" #1 collaborator was "Pfizer" with 4 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Virginia Research Center" are "COVID-19" (3 trials), "SARS-CoV-2 Infection" (3 trials), "Cardiovascular Disease" (2 trials), "Low Back Pain" (2 trials) and "Clostridium Difficile Associated Disease" (1 trials). Many other conditions were trialed in "Virginia Research Center" in a lesser frequency.

Most popular intervention types in "Virginia Research Center" are "Biological" (8 trials), "Drug" (5 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "BNT162b2" (2 trials), "bococizumab (PF-04950615)" (2 trials), "BNT162b1" (1 trials) and "BNT162b2 20mcg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Virginia Research Center" are 12 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Virginia Research Center". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Virginia Research Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Virginia Research Center, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".